Alternate-Day Buprenorphine. Phase V - 6

National Institutes of Health (NIH)

Status and phase: Completed; Phase 1

Conditions: Opioid-Related Disorders

Treatments: Drug: Buprenorphine

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00000224

NIDA-06969-6

R01-06969-6

Details and patient eligibility

About

The purpose of this study is to evaluate buprenorphine blockade challenge.

Sex: All

Ages: 30 to 49 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.